GHRP-6, Agonist of ghrelin receptor, CAS No.rp174131, Agonist of ghrelin receptor

CAS: rp174131 Cat. No.: rp174131 PubChem CID: 4345065
AVAILABLE TO ORDER
GRADE & PURITY Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools.
★
Size
Germany (EU)
USA*
Price
Qty
500μg
rp174131-500μg
Made to order · 8–12 wks
€2,082.49
1mg
rp174131-1mg
Made to order · 8–12 wks
€3,470.87
Enter a quantity for the sizes you want to add.

Specifications

Product Name
GHRP-6, Agonist of ghrelin receptor, CAS No.rp174131
Grade
Moligand™
Specifications & Purity
Moligand™
Action Type
AGONIST
Mechanism of action
Agonist of ghrelin receptor
CAS
rp174131
Molecule Type
Peptide
Product Line
biological_products
Storage and Shipping
Storage
Room temperature

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
SubclassAmino acids, peptides, and analogues
Intermediate Tree Nodes Peptides
Direct ParentOligopeptides
Alternative Parents Phenylalanine and derivatives  Histidine and derivatives  N-acyl-alpha amino acids and derivatives  Tryptamines and derivatives  Alpha amino acid amides  Alanine and derivatives  3-alkylindoles  Amphetamines and derivatives  Aralkylamines  Substituted pyrroles  Fatty amides  Imidazoles  Heteroaromatic compounds  Secondary carboxylic acid amides  Primary carboxylic acid amides  Azacyclic compounds  Carbonyl compounds  Hydrocarbon derivatives  Monoalkylamines  Organic oxides  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Alpha-oligopeptide - Phenylalanine or derivatives - Histidine or derivatives - N-acyl-alpha amino acid or derivatives - Alpha-amino acid amide - Triptan - Alanine or derivatives - N-substituted-alpha-amino acid - Alpha-amino acid or derivatives - Amphetamine or derivatives - 3-alkylindole - Indole or derivatives - Indole - Aralkylamine - Monocyclic benzene moiety - Substituted pyrrole - Fatty amide - Fatty acyl - Benzenoid - Heteroaromatic compound - Pyrrole - Imidazole - Azole - Amino acid or derivatives - Carboxamide group - Secondary carboxylic acid amide - Primary carboxylic acid amide - Organoheterocyclic compound - Azacycle - Amine - Organic oxide - Organic oxygen compound - Carbonyl group - Hydrocarbon derivative - Organic nitrogen compound - Primary amine - Organooxygen compound - Primary aliphatic amine - Organonitrogen compound - Aromatic heteropolycyclic compound
DescriptionThis compound belongs to the class of organic compounds known as oligopeptides. These are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds.
External Descriptors Not available
3D Structure
Interactive Chemical Structure Model





Associated Targets(Human)
GHSR Tclin Growth hormone secretagogue receptor type 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
Certificates (CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Genetic information
Reference
  • 1. Kinetics and inhibition of recombinant human cystathionine gamma-lyase. Toward the rational control of transsulfuration., The Journal of biological chemistry, Steegborn, C C and 7 more authors.
  • 2. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences., Proceedings of the National Academy of Sciences of the United States of America, Strausberg, Robert L RL and 83 more authors.
  • 3. Genomic basis of cystathioninuria (MIM 219500) revealed by multiple mutations in cystathionine gamma-lyase (CTH)., Human genetics, Wang, Jian J and Hegele, Robert A RA.
  • 4. Cloning and nucleotide sequence of human liver cDNA encoding for cystathionine gamma-lyase., Biochemical and biophysical research communications, Lu, Y Y, O'Dowd, B F BF, Orrego, H H and Israel, Y Y.
  • 5. Single nucleotide polymorphism in CTH associated with variation in plasma homocysteine concentration., Clinical genetics, Wang, J J, Huff, A M AM, Spence, J D JD and Hegele, R A RA.
  • 6. Cystathionine gamma-lyase overexpression inhibits cell proliferation via a H2S-dependent modulation of ERK1/2 phosphorylation and p21Cip/WAK-1., The Journal of biological chemistry, Yang, Guangdong G, Cao, Kun K, Wu, Lingyun L and Wang, Rui R.
  • 7. The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)., Genome research, Gerhard, Daniela S DS and 115 more authors.
  • 8. Towards a proteome-scale map of the human protein-protein interaction network., Nature, Rual, Jean-François JF and 37 more authors.
  • 9. The DNA sequence and biological annotation of human chromosome 1., Nature, Gregory, S G SG and 178 more authors.
  • 10. Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer., International journal of cancer, Moore, Lee E LE and 14 more authors. more
Solution Calculators
Reviews

Customer Reviews

Application Protocols

No item-specific, validated application protocols are provided for this SKU. Refer to the CoA/Spec Sheet for any assay examples that may accompany a particular lot.

General laboratory guidance for peptide ligand use (literature-based; not specifications):

  • Stock preparation: Dissolve to 1–10 mM in DMSO or in water containing ~0.1% acetic acid; vortex gently and, if necessary, sonicate briefly. Filter-sterilize for cell assays.
  • Working solutions: Dilute stocks into assay buffer to desired concentrations; typical final DMSO ≤0.5–1%. Prepare fresh or use single-use aliquots to avoid freeze–thaw.
  • Receptor assays: For calcium flux or β-arrestin assays, perform concentration–response (8–12 points, half-log spacing) and include a vehicle control and a known reference agonist.
  • Data quality: Monitor for adsorption losses by using low-bind plastics and adding small amounts of carrier protein (e.g., 0.1% BSA) if compatible with the assay.

These suggestions are for general research context only and do not constitute item-specific directions.

Biological Roles

General, literature-based background (not item-specific claims):

  • Pharmacological class: Synthetic growth hormone secretagogue peptide; agonist of the ghrelin receptor (GHS-R1a), a GPCR broadly expressed in metabolic tissues and CNS.
  • Mechanism (cellular): Receptor activation typically couples to Gq/11, elevating intracellular Ca2+ and activating downstream kinases; β-arrestin pathways may also be engaged depending on context.
  • Structure–activity features: Incorporation of D-Trp and D-Phe improves metabolic stability and modulates receptor selectivity versus endogenous ghrelin and related ligands.
  • Experimental utilities: Used to probe receptor signaling bias, receptor desensitization/internalization, and cross-talk with dopaminergic/cholinergic pathways in cellular models.
  • Stability considerations: Aromatic residues (Trp) can undergo oxidation; His can coordinate metals and participate in acid–base catalysis. C-terminal amidation reduces susceptibility to carboxypeptidases.
  • ADME (in vitro perspective): As a peptide, exhibits limited passive permeability; often evaluated in membrane receptor formats or with delivery aids in preclinical systems. Serum proteases can degrade linear peptides, though D-residues confer partial resistance.

Important: All uses are for research and laboratory study only; no medical, diagnostic, or therapeutic use is intended or implied.

Buffer Applications

This product is a bioactive peptide ligand, not a buffering reagent. Therefore, it is not typically used to prepare buffer systems.

Practical guidance (general):

  • Choose buffers that maintain peptide solubility and biological activity (e.g., acetate, citrate, or phosphate at pH 5.0–7.4 depending on assay).
  • Low concentrations of acid (e.g., 0.1% acetic acid) may aid initial dissolution before dilution into the final assay buffer.

Item-specific buffer/formulation details: Not specified for this item; refer to CoA/Spec Sheet.

Green Alternatives

While GHRP-6 itself is a peptide analyte/ligand, greener choices arise primarily in the solvents and coupling reagents used around its handling and synthesis.

Greener handling/dissolution options (general):

  • Prefer aqueous buffers over high percentages of organic solvents when assay-compatible.
  • Use minimal DMSO fractions (≤0.5–1%) in working solutions; consider ethanol/water only if biologically acceptable, acknowledging peptide solubility limits.

Greener peptide synthesis considerations (literature/general):

  • Solvents: Replace DMF/NMP with NBP (N-butylpyrrolidone) or PolarClean, and dilute with EtOAc or CPME where feasible. Water-assisted SPPS and micellar media are emerging for certain steps.
  • Coupling reagents: Explore greener carbodiimides (e.g., EDC) and OxymaPure with reduced excess, or enzymatic ligation strategies, to curb HOBt/HBTU safety and environmental burdens.
  • Deprotection: Optimize piperidine use in Fmoc chemistry with lower concentration or substitutes (e.g., piperazine, DBU blends) to reduce toxicity.

Compact comparison (illustrative; not item-specific):

  • DMF (benchmark) vs NBP: NBP offers lower toxicity and higher boiling point; viscosity can slow diffusion—optimize mixing/agitation.
  • DCM cleavage vs EtOAc/Me-THF: Greener ethers/esters reduce halogenated waste; monitor swelling/kinetics on your resin.

Note: These are general green-chemistry recommendations; item-specific manufacturing details for this SKU are not specified.

Pharmaceutical Uses

This product is supplied strictly for research use only.

General formulation-context notes (literature; not item-specific or for human/clinical use):

  • Peptide tool compounds like GHRP-6 are sometimes formulated for preclinical laboratory studies in aqueous vehicles (e.g., saline, acetate buffer) with stabilizers (e.g., mannitol) and stored frozen in aliquots to preserve activity. These practices are provided solely as general laboratory context, not as specifications or usage directions for this SKU.
  • Pharmacopeial status, compendial tests, and excipient roles for this specific item are Not specified for this item; refer to CoA/Spec Sheet.

No medical, diagnostic, or therapeutic claims are made or implied for this product.

Physical Properties

Item-specific measured properties were not provided for this SKU. Do not treat the following as specifications; consult the CoA/Spec Sheet for exact values.

  • Appearance (item-specific): Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Formula (item-specific): Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight (item-specific): Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point, boiling point, density, refractive index: Not specified for this item; refer to CoA/Spec Sheet.

Literature/general characteristics for GHRP-6 (for guidance only):

  • Typical MW (free base): ~873 g/mol (literature); acetate salt forms exhibit higher apparent MW.
  • Physical form: Generally isolated as a white to off-white solid peptide.
  • Solubility: Readily soluble in water and aqueous buffers when slightly acidified (e.g., 0.1% acetic acid); soluble in DMSO; limited solubility in neat organic solvents. Actual solubility depends on counterion and lyophilization excipients.
  • pI/pKa (qualitative): Multiple basic centers (His, Lys; imidazole pKa ~6, ε-NH3+ pKa ~10.5, literature) and backbone/terminus ionizations; overall cationic under mildly acidic conditions.

Important: For quantitative use (e.g., receptor binding assays), determine exact peptide content (mg-to-µmol conversion) from the item’s CoA, which may report peptide content, water/volatile content, and counterion content.

Quality and Grades
  • Item-specific grade: Moligand™ (as provided in Product Data).

What Moligand™ typically implies (general):

  • Designed for small-molecule/ligand library applications such as receptor screening, binding assays, and phenotypic profiling.
  • Emphasis on identity confirmation and suitability for high-throughput screening (HTS) or medicinal chemistry workflows, rather than on specific analytical solvent grades.

Quality considerations for peptide ligands (general guidance; consult the item’s CoA/Spec Sheet):

  • Identity confirmation: Commonly by high-resolution MS and analytical HPLC; peptide purity for screening libraries often ≥90% by area, but actual purity for this item is Not specified for this item; refer to CoA/Spec Sheet.
  • Counterion form: Free base vs. acetate/TFA salts can influence solubility and assay performance; specific counterion for this item is Not specified for this item; refer to CoA/Spec Sheet.
  • Residual solvents, water content, and peptide content: Critical for accurate dosing; values are Not specified for this item; refer to CoA/Spec Sheet.

Implications for end users:

  • For quantitative biology/chemistry, use the CoA-reported peptide content to calculate exact molarity.
  • If low UV background is required (e.g., HPLC detection at 214/280 nm), confirm UV profile and purity trace in the CoA.
Reaction and Applications

Research applications (general for GHRP-6; expand from manufacturer’s “research use only” note):

  • Receptor pharmacology: Widely used as a reference agonist for ghrelin/GRLN receptor (GHS-R1a) in binding, calcium flux, cAMP, β-arrestin recruitment, and ERK phosphorylation assays (literature). Useful as a positive control in GHSR assay development and HTS.
  • Cell biology: Tool compound to probe growth hormone secretagogue signaling, desensitization, and biased agonism in recombinant or primary cell systems (literature). No clinical/diagnostic use is implied.
  • Structural biology: Ligand for validating receptor expression and signaling in engineered cell lines; can assist in receptor-ligand docking validation or benchmarking computational models with experimental readouts.
  • Peptide chemistry: Benchmark hexapeptide for studying D-amino-acid effects on proteolysis resistance and receptor selectivity; suitable for method development in HPLC/LC–MS peptide analytics.

Practical tips (general):

  • Prepare concentrated DMSO or mildly acidified aqueous stocks to minimize adsorption to plastics; use low-bind tubes and pipette tips.
  • Filter sterilize aqueous working solutions (0.22 µm) when needed for cell-based assays; avoid heat sterilization.
  • Track exposure to light/oxidants due to two Trp residues; store aliquots under inert atmosphere if long-term in solution.

Item-specific validated applications: Not specified for this item; refer to CoA/Spec Sheet.

Reaction Conditions

No item-specific reaction conditions pertain to this SKU. The following are general, literature-based guidelines for synthesizing and handling hexapeptides such as GHRP-6 via Fmoc-SPPS (for method context only):

  • Resin selection: Rink amide (to afford C-terminal –CONH2). Typical loading 0.3–0.7 mmol/g.
  • Deprotection: 20% piperidine in DMF (or greener alternatives: piperazine/DBU mixes; NBP as solvent). 2×5–10 min at rt.
  • Coupling: 3–5 eq Fmoc-amino acid with HATU or HBTU (or EDC/Oxyma) and 4–8 eq DIPEA, 15–60 min per step at rt with efficient agitation. Double coupling for hindered residues (e.g., Fmoc-D-Phe, Fmoc-D-Trp).
  • Side-chain protection: His(Trt), Lys(Boc or Cbz). Ensure compatibility with final TFA cleavage.
  • Cleavage: TFA/H2O/TIS (95:2.5:2.5) for 1–3 h; scavenge for indole-containing peptides (e.g., thioanisole) as needed to minimize Trp oxidation.
  • Purification: Preparative RP-HPLC (C18), water/acetonitrile with 0.1% TFA or formic acid; monitor at 214 and 280 nm. Lyophilize to obtain the peptide as a solid.
  • Oxidation control: Minimize air/light exposure; consider inert gas sparging and antioxidant scavengers during cleavage for Trp-rich sequences.

These conditions are provided for general laboratory context only and are not specifications for this product.

Safety and Handling
  • GHS/SDS information (item-specific):

    • Signal Word: Not specified for this item; refer to SDS.
    • Hazard Statements: Not specified for this item; refer to SDS.
    • GHS Classification and Pictograms: Not specified for this item; refer to SDS.
  • General laboratory precautions for peptides (guidance, not a substitute for SDS):

    • Avoid inhalation of powders and contact with skin/eyes. Handle in a fume hood or ventilated enclosure during weighing and dissolution.
    • Wear appropriate PPE: lab coat, safety glasses, and nitrile gloves.
    • Prevent aerosol generation during reconstitution; gently add solvent down the vial wall.
    • Incompatibilities: Strong oxidizers may degrade peptides; avoid prolonged exposure to basic solutions (can promote racemization/β-elimination in some residues) and to light/air if aromatic residues are present.
    • Hygroscopicity: Many lyophilized peptides are hygroscopic; keep containers tightly closed to prevent moisture uptake.
  • First-aid (summary; defer to SDS):

    • Inhalation: Move to fresh air; seek medical attention if symptoms occur.
    • Skin/eye contact: Rinse with water for several minutes; remove contaminated clothing; seek medical advice if irritation persists.
    • Ingestion: Rinse mouth; do not induce vomiting; seek medical attention.
  • Waste: Dispose of peptide solutions and contaminated materials according to institutional and local regulations for organic laboratory waste.

Solvent Selection

GHRP-6 is a cationic/neutral amphiphilic hexapeptide with multiple aromatics and a basic lysine side chain. Solvent choice affects solubility, stability, and assay compatibility.

  • Polarity/miscibility (general peptide behavior):

    • Water: Good solubility when acidified (e.g., 0.1% v/v acetic acid or dilute HCl) to protonate His/Lys; neutral pH solubility is variable.
    • Aqueous buffers: PBS, acetate, citrate; avoid high ionic strength if aggregation is observed.
    • DMSO: Excellent co-solvent for stock solutions; typically compatible at ≤1–2% v/v in biological assays.
    • Alcohols (MeOH/EtOH): Limited use; may be used in small fractions with water.
  • Practical selection:

    • Initial dissolution: Start with DMSO or 10–20% DMSO/water, or water with 0.1% acetic acid; then dilute into buffer.
    • For receptor assays: Prefer aqueous buffers; keep final DMSO ≤0.5–1.0% to minimize biological effects.
    • Avoid strong base during dissolution to limit side reactions and epimerization.
  • Comparison (general):

    • DMSO vs. water: DMSO maximizes solubility for concentrated stocks; water/buffer offers best biocompatibility.
    • Acetate/citrate buffers can enhance solubility via protonation; phosphate buffers maintain pH near neutrality but may reduce solubility if the peptide is near its isoelectric point.

Item-specific solvent recommendations: Not specified for this item; refer to CoA/Spec Sheet.

Storage and Reconstitution
  • Storage (item-specific): Store at room temperature (per Product Data). Protect from moisture and light by keeping the container tightly closed in a dry place. For authoritative instructions, refer to the product label and CoA/Spec Sheet.

  • Shipping (item-specific): Not specified for this item; refer to CoA/Spec Sheet.

  • Reconstitution (item-specific): Not specified for this item; refer to CoA/Spec Sheet.

  • General guidance for peptide handling (literature; not specifications):

    • Reconstitution: Start with DMSO or mildly acidified water (e.g., 0.1% acetic acid), then dilute with buffer to working concentration. Avoid vigorous foaming to limit adsorption/denaturation.
    • Aliquoting: Prepare single-use aliquots to minimize repeated temperature cycling. If longer-term storage in solution is required, keep at low temperature and protect from light/air; add compatible stabilizers if assay permits.
    • Container choice: Use low-bind polypropylene; pre-rinse with solvent to reduce peptide losses to surfaces.
  • Research Use: For research use only (as provided).

Structure and Identity

GHRP-6 is a synthetic hexapeptide ligand widely used in receptor pharmacology and peptide chemistry research.

  • Item-specific identifiers (from Product Data):

    • SKU: rp174131
    • Product Name: GHRP-6
    • CAS: rp174131 (as provided)
    • PubChem CID: 4345065
    • InChIKey: 411982 (as provided)
    • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Literature identity (for general reference; not item-specific specifications):

    • Common sequence: His–D-Trp–Ala–Trp–D-Phe–Lys–NH2
    • Peptide class: Growth hormone secretagogue/ghrelin receptor agonist peptide (hexapeptide)
    • Typical free-base MW (literature): ~873 g/mol; acetate salt often encountered at higher MW.
  • Structural features (general):

    • Contains two tryptophan indole rings (aromatic, H-bond donating/accepting), one phenylalanine phenyl ring, and an imidazole ring from histidine.
    • Two D-amino acids (D-Trp, D-Phe) confer proteolytic stability and receptor selectivity.
    • C-terminal amidation (–CONH2) reduces overall acidity and increases stability.
    • Primary ε-amino side chain on lysine (protonatable, increases basicity/solubility in acidic media).
  • 2D description in words (general): A linear hexapeptide backbone with alternating L/D stereocenters at Trp and Phe, bearing three aromatic side chains (His imidazole, two Trp indoles, one Phe phenyl) and a basic Lys side chain; N-terminus free, C-terminus amidated.

Synthetic Utility

From a synthetic chemistry perspective, GHRP-6 exemplifies several useful design and method-development features in peptide science (general information):

  • Backbone elements: Linear hexapeptide with five backbone amide bonds and a C-terminal amide; showcases control of secondary structure via aromatic stacking (Trp/Phe) and basic side chains (Lys).
  • Stereochemistry: Incorporation of D-Trp and D-Phe allows investigation of stereochemical effects on receptor affinity and proteolytic stability.
  • Protective group strategies: Model substrate for Fmoc/tBu SPPS, including handling of Boc/Trt on His and side-chain protection on Lys (e.g., Boc, Cbz, or Alloc) with orthogonal deprotection sequences.
  • Late-stage diversification: Aromatic residues enable electrophilic aromatic substitution or cross-coupling on suitably protected analogs; Lys ε-amine provides a handle for acylation, PEGylation, or fluorophore/biotin conjugation.
  • Fragment coupling: Useful in demonstrating segment condensation (e.g., [3+3] couplings) and testing coupling cocktails (HATU/Oxyma/DIPEA vs. EDC/Oxyma).
  • Analytical benchmarking: Ideal for validating peptide LC–MS methods (214/280 nm), examining indole oxidation products, and studying RP-HPLC retention as a function of ion-pairing and gradient slope.

These synthetic utility notes are general; they do not specify the manufacturing route or modifications for this SKU.

Target Specificity

Target/biomolecule specificity testing is not applicable to this SKU in the sense of antibody/biologic characterization (no clone, isotype, or species cross-reactivity).

General literature note: GHRP-6 is commonly used as a ghrelin receptor (GHS-R1a) agonist in receptor pharmacology studies; however, no item-specific potency, selectivity, or bioactivity data are provided for this SKU. Refer to primary literature and to the CoA/Spec Sheet for any available assay data.

Frequently Asked Questions

What is Moligand??
Moligand? is one of Aladdin Scientific's premium product lines, formulated for high-purity applications across multiple workflows. Compared to standard grades in the same workflow, Moligand? products typically offer tighter specifications, more rigorous QC, and stronger lot-to-lot consistency.
How should this product be stored?
Store at room temperature.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is rp174131. InChIKey WZHKXNSOCOQYQX-UHFFFAOYSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Need help choosing the grade?

Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.

View Moligand™ grade guide →

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.